+
in $
+2.00%
Clarivate Plc
in $
+0.57%
Equitrans Midstream Corporation
in $
-37.24%
Cano Health, Inc.
VODPF ETRN PLTR
Price 0.85 12.42 69.99
Movement +$ 0.01 +$ 0.07 -$ 5.93
Market Cap. 21.7 B 5.4 B 159.4 B
Volume 4,600 194.2 M 89.5 M
Volume μ 14,795 9.2 M 76.7 M
EPS TTM 0.09 0.90 0.20
P/E TTM 9.44 13.80 349.95
Dividend Yield TTM 6% 1% -%
Shares Outstanding 25,499 M 436 M 2,278 M
Earnings Call May 12, 2025 July 19, 2024 Feb. 3, 2025

Financial Comparison

Financial Statements
Click to show
CLVT-PA
ETRN
CANO-WT
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2018
    • 2017
Profitability
Industry Average
Profit Margin
-329.57% YoY
-0.09
-1.49
-0.35
Gross Margin
-66.23% YoY
0.49
0.64
0.39
Operating Margin
+1,513.70% YoY
0.11
-1.48
0.10
EBT Margin
-289.36% YoY
-0.07
-1.50
-0.39
ETR
-% YoY
-
-
EPS
-330.88% YoY
-0.72
-5.86
-1.36
EPS Dil.
-329.41% YoY
-0.72
-5.84
-1.36
ROA
-296.09% YoY
-0.04
-0.28
-0.07
ROE
-282.18% YoY
-0.04
-0.58
-0.15
ROIC
+1,521.74% YoY
0.08
-0.33
0.02
Takeaways
  • Positive 5Y revenue growth of +23.37% and -23.37% for the past 10 Years
  • The profit margin of -0.35 implies a negative sign compared to the industry avg. of -0.09
Market Prospects
P/E
+79.14% YoY
0.78
-1.42
-6.83
P/B
+20.24% YoY
3.22
0.83
1.04
P/TB
+20.24% YoY
3.22
0.83
1.04
Earnings Yield
-379.34% YoY
-0.06
-0.70
-0.15
Other Metrics
EBITDA[in mil.]
-32.36% YoY
-
1,300
982
EBITDA Margin
-30.82% YoY
0.25
0.49
0.37
WA[in mil.]
-0.67% YoY
-
676
671
WA Dil.[in mil.]
-0.67% YoY
-
676
671
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings CLVT-PA ETRN
Earnings Call Nov. 5, 2024 Oct. 29, 2024
Avg. EPS Forecast - 0.23
Potential Delta 1 % %
Avg. Revenue Forecast - Mil. - Mil.
Potential Delta - % - %
Dividends
Company Average
Vodafone Group Public Limited Company
$0.05
Industry Average
Telecommunications Services
$0.39
Company Average
Equitrans Midstream Corporation
$0.15
Industry Average
Oil & Gas Midstream
$0.51

Investor Relations

Index
PLTR
Annual Statement Feb. 20, 2024, midnight
Quarterly Statement Nov. 5, 2024, midnight
Earnings Call Nov. 4, 2024, 8:43 p.m.
Next Earnings Call Feb. 3, 2025
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
VODPF
Annual Statement n/a
Quarterly Statement June 14, 2024, midnight
Earnings Call n/a
Next Earnings Call May 12, 2025
Shareholder Meeting n/a
FDA Filing n/a
Lobby Disclosure n/a
ETRN
Annual Statement Feb. 20, 2024, midnight
Quarterly Statement July 19, 2024, midnight
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
FDA Filing n/a

Strategic Comparison

Risks & Opportunities
Risk Factors [Item 1A]
25x for ETRN

Feb. 20, 2024

The regulatory approval process for the construction of new transmission assets is very challenging, and, as demonstrated with the MVP pipeline, has resulted in significantly increased costs and delayed targeted in-service dates, and decisions by regulatory and/or judicial authorities in pending or potential proceedings relevant to the development of midstream assets, particularly any litigation instituted in the Fourth Circuit, such as regarding the MVP Southgate project and/or expansions or extensions of the MVP, are likely to impact our or the MVP Joint Venture's ability to obtain or maintain in effect all approvals and authorizations, including as may be necessary to complete certain projects in a timely manner or at all, or our ability to achieve the expected investment returns on the projects.